You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Felzartamab

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lupus Nephritis Trial (Felzartamab)

Not yet recruiting
  • Lupus Nephritis
  • Felzartamab
  • (no location specified)
Sep 26, 2023

Antibody-mediated Rejection Trial in Vienna, Berlin (Felzartamab, Placebo)

Recruiting
  • Antibody-mediated Rejection
  • Felzartamab
  • Placebo
  • Vienna, Austria
  • +1 more
Aug 23, 2022

Membranous Nephropathy Trial in Bergamo, Ranica (MOR202)

Recruiting
  • Membranous Nephropathy
  • Bergamo, BG, Italy
  • +1 more
Mar 4, 2022

Immunoglobulin A (IgA) Nephropathy Trial in Worldwide (Felzartamab, Placebo)

Recruiting
  • Immunoglobulin A (IgA) Nephropathy
  • Felzartamab
  • Placebo
  • Oxnard, California
  • +59 more
Dec 12, 2022

Glomerulonephritis, Membranous Nephropathy, antiPLA2R Positive Trial in Worldwide (MOR202)

Active, not recruiting
  • Glomerulonephritis
  • +2 more
  • Tbilisi, Georgia
  • +24 more
Aug 23, 2022

Glomerulonephritis, Membranous, antiPLA2R Positive Trial in Worldwide (MOR202)

Completed
  • Glomerulonephritis, Membranous
  • antiPLA2R Positive
  • Azusa, California
  • +44 more
Dec 12, 2022

Multiple Myeloma Trial in Austria, Germany (MOR03087 phase 1 dose escalation, MOR03087, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • MOR03087 phase 1 dose escalation
  • +4 more
  • Vienna, Austria
  • +9 more
Nov 12, 2021